FDA approves RSV monoclonal antibody to protect infants and young children, a potential game-changer for a disease that is the No. 1 cause of hospitalization of babies in this country
Labels:
#health
No comments
Read More About This Article: https://ift.tt/gU7BsH1
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment